BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23906449)

  • 1. [Analysis of L-asparaginase induced elevation of blood ammonia and hepatic encephalopathy].
    Li Y; Ren HY; Cen XN; Yin Y; Liang ZY
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):578-80. PubMed ID: 23906449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct fluctuations of ammonia levels during asparaginase therapy for childhood acute leukemia.
    Steiner M; Attarbaschi A; Kastner U; Dworzak M; Haas OA; Gadner H; Mann G
    Pediatr Blood Cancer; 2007 Oct; 49(5):640-2. PubMed ID: 16941647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
    Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
    Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia.
    Merlen C; Bonnefoy A; Wagner E; Dedeken L; Leclerc JM; Laverdière C; Rivard GE
    Pediatr Blood Cancer; 2015 Aug; 62(8):1381-7. PubMed ID: 25820776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient hyperammonemia due to L-asparaginase therapy in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma.
    Jörck C; Kiess W; Weigel JF; Mütze U; Bierbach U; Beblo S
    Pediatr Hematol Oncol; 2011 Feb; 28(1):3-9. PubMed ID: 20615069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
    Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fulminant hepatitis possibly caused by L-asparaginase during induction chemotherapy in a patient with acute lymphoblastic leukemia].
    Tsutsui M; Koike M; Komatsu N
    Rinsho Ketsueki; 2012 May; 53(5):531-4. PubMed ID: 22728556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute central nervous system complications and ammonium levels in adult patients with acute lymphoblastic leukemia receiving l-asparaginase.
    Strickler N; Balabanov S; Casauro K; Schanz U; Manz MG; Gerber B
    Leuk Lymphoma; 2018 Apr; 59(4):855-862. PubMed ID: 28728499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma ammonia concentration after L-asparaginase therapy in 27 dogs with high-grade lymphoma or leukemia.
    Speas AL; Lyles SE; Wirth KA; Fahey CE; Kow K; Lejeune AT; Milner RJ
    J Vet Emerg Crit Care (San Antonio); 2018 Mar; 28(2):130-139. PubMed ID: 29469204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin deficiency after prolonged asparaginase treatment in children with acute lymphoblastic leukemia.
    Ranta S; Heyman MM; Jahnukainen K; Taskinen M; Saarinen-Pihkala UM; Frisk T; Söderhäll S; Petrini P; Mäkipernaa AM
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):749-56. PubMed ID: 24056293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase.
    Mattioli Belmonte M; Gugliotta L; Delvos U; Catani L; Vianelli N; Cascione ML; Belardinelli AR; Mottola L; Tura S
    Haematologica; 1991; 76(3):209-14. PubMed ID: 1743591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of ammonia concentration as a diagnostic test in monitoring of the treatment with L-asparaginase in children with acute lymphoblastic leukemia.
    Czogała M; Balwierz W; Sztefko K; Rogatko I
    Biomed Res Int; 2014; 2014():945860. PubMed ID: 25157375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbalanced coagulation-fibrinolysis potential during L-asparaginase therapy in children with acute lymphoblastic leukaemia.
    Semeraro N; Montemurro P; Giordano P; Schettini F; Santoro N; De Mattia D; Giordano D; Conese M; Colucci M
    Thromb Haemost; 1990 Aug; 64(1):38-40. PubMed ID: 2274927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
    Beinart G; Damon L
    Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ex vivo production of ammonia predicts L-asparaginase biological activity in children with acute lymphoblastic leukemia.
    Watanabe S; Miyake K; Ogawa C; Matsumoto H; Yoshida K; Hirabayashi S; Hasegawa D; Inoue T; Kizu J; Machida R; Ohara A; Hosoya R; Manabe A
    Int J Hematol; 2009 Oct; 90(3):347-352. PubMed ID: 19768519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and adverse event profiling of pegylated L-asparaginase combined chemotherapy in the treatment of lymphoma].
    Ping LY; Zheng W; Wang XP; Xie Y; Lin NJ; Tu MF; Ying ZT; Zhang C; Liu WP; Deng LJ; Zhu J; Song YQ
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3257-60. PubMed ID: 23328509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular coagulation phenomena associated with prevalent fall in fibrinogen and plasminogen during L-asparaginase treatment in leukemic children.
    Legnani C; Palareti G; Pession A; Poggi M; Vecchi V; Bianchini B; Coccheri S
    Haemostasis; 1988; 18(3):179-86. PubMed ID: 3181817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of anti L-asparaginase antibody in childhood acute lymphoblastic leukemia].
    Akazai A; Oda M; Nishiuchi R; Horiuchi T; Henmi M; Manki A; Seino Y
    Rinsho Ketsueki; 1996 Feb; 37(2):95-100. PubMed ID: 8852025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia.
    Zaunschirm A; Muntean W
    Pediatr Hematol Oncol; 1986; 3(1):19-25. PubMed ID: 3153215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.